Cargando…
Management of Adverse Reactions for BCMA-Directed Therapy in Relapsed Multiple Myeloma: A Focused Review
Anti-B-cell maturation antigen therapies consisting of bispecific antibodies, antibody–drug conjugates, and chimeric antigen receptor T cells have shown promising results in relapsed refractory multiple myeloma (RRMM). However, the severe side effects include cytokine release syndrome, immune effect...
Autores principales: | Khanam, Razwana, Faiman, Beth, Batool, Saba, Najmuddin, Mohammed Musa, Usman, Rana, Kuriakose, Kiran, Ahmed, Arooj, Rehman, Mohammad Ebad Ur, Roksana, Zinath, Syed, Zain, Anwer, Faiz, Raza, Shahzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487885/ https://www.ncbi.nlm.nih.gov/pubmed/37685606 http://dx.doi.org/10.3390/jcm12175539 |
Ejemplares similares
-
The Role of Bispecific Antibodies in Relapsed Refractory Multiple Myeloma: A Systematic Review
por: Khanam, Razwana, et al.
Publicado: (2023) -
Safety of CAR-T Cell Therapy in Patients With Renal Failure/Acute Kidney Injury: Focused Review
por: Khan, Israr, et al.
Publicado: (2023) -
Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice
por: Dima, Danai, et al.
Publicado: (2023) -
Analysis of risk factors and prognostic factors of brain metastasis in gastric cancer: a surveillance, epidemiology and end-results database study
por: Rehman, Mohammad Ebad Ur, et al.
Publicado: (2023) -
The Relationship Between Exacerbation of Pachymeningitis and Chemotherapy: A Case Report
por: Maliha, Maisha, et al.
Publicado: (2022)